3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
2
Phase 1
2
Phase 2
1
Status
Completed
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Thoracic
1
Other hematologic neoplasm
1
Conditions
Leukemia, Myeloid, Acute
1
Hypoxia
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Magnetic Resonance Spectroscopy
59
Cyclophosphamide
44
pembrolizumab
34
Radiotherapy
30
fludarabine
27
Nivolumab
26
Biopsy
26
Metformin
22
Fluorodeoxyglucose F18
22
Specimen Handling
20
Bevacizumab
20
Temozolomide
17
Radiosurgery
17
Cisplatin
16
Carboplatin
14
Fluorouracil
13
Dexamethasone
13
Paclitaxel
12
Gemcitabine
12
Etoposide
12
gallium 68 PSMA-11
11
durvalumab
11
X-Rays
11
Surgical Procedures, Operative
11
Radiation
11
Positron Emission Tomography Computed Tomography
11
Letrozole
11
Irinotecan
11
Ipilimumab
11
Surveys and Questionnaires
10
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase EARLY_PHASE1
×
OTHER
×
Atovaquone
×
Clear all
NCT03568994
2026-01-27
ATACC AML
Baylor College of Medicine
Phase EARLY_PHASE1
Completed
26 enrolled
NCT02628080
2019-09-04
ATOM
University of Oxford
Phase EARLY_PHASE1
Completed
46 enrolled